Navigation Links
Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems
Date:3/2/2011

CAMBRIDGE, Mass., March 2, 2011 /PRNewswire/ -- Berg Biosystems, LLC (Berg) and GNS Healthcare, Inc. (GNS), a subsidiary of Via Science, today announced that they have entered into a joint venture named MAP Biosystems, LLC (MAP) to combine their unique capabilities to accelerate advancements in critical biomedical research.  MAP will utilize a combination of Berg's novel Interrogative Biology drug discovery platform, and GNS's patented supercomputer-driven REFS™ modeling and simulation platform, to unlock the key molecular drivers of complex diseases and drug efficacy and safety.  The joint venture will focus on the repositioning of existing drugs for use in new indications with collaborators. Financial terms of the joint venture were not disclosed.

Dr. Niven R. Narain, President & CTO of Berg, said, "MAP represents to biological investigation a new paradigm of physiological understanding based upon a robust network intelligence of disease.  The unique combination of unbiased systems biology and artificial-intelligence based systems engineering creates a true data driven approach to therapeutic and diagnostic development."

Narain will be speaking on applications of the Berg discovery platform and the GNS Healthcare platform in La Jolla, CA on March 2nd at the AACR-NCI sponsored conference on Systems Biology: Confronting the Complexity of Cancer. The title of the talk is "Inferring causality to unravel the network intelligence of cancer by employing a novel systems biology drug discovery platform."

The combined platforms will allow for insight into biology drawing from "omic-based", pre-clinical, and clinical data feeds employing computational biology methods to create a differential understanding of disease and health.  The collaboration signifies a novel innovative step in medicine that seeks to understand causality and use it as a template for a new generation of drug development.

"MAP has in its arsenal two unparalleled yet complementary technologies – one to generate uniquely deep and broad biological readouts of disease biology and another to readily turn those readouts into knowledge," said Colin C. Hill, CEO and co-founder of GNS Healthcare.  "We are looking forward to unraveling hidden mechanisms of efficacy and toxicity of drugs to rapidly address unmet medical needs using these technologies."

About Berg Biosystems, LLC

Berg Biosystems is a Boston, Massachusetts based company that employs a novel approach to systems biology and utilizes systems engineering and bioinformatic modules to cross-validate biological output. The Berg Interrogative Biology™ Drug Discovery Platform allows for rapid and precise identification of therapeutic and biomarker candidates for drug discovery and development. The company uses network biology templates to mine disease pathophysiology.

About REFS™

REFS™ is comprised of integrated machine learning algorithms and software that extract "causal" relationships from complex, multi-dimensional data and enable the simulation of billions of "what if?" hypotheses to explore novel unseen conditions and predictions forward in time. This model-centric discovery and simulation approach represents a paradigm shift in data analysis, leapfrogging existing approaches such as high-dimensional pattern matching.  REFS™ is licensed to GNS Healthcare from Via Science.

About GNS Healthcare, Inc.

GNS Healthcare, a subsidiary of Via Science, is a healthcare IT company that applies machine learning and simulation technology to optimize patient treatment in partnership with health insurance companies, pharmacy benefit managers, and pharmaceutical and biotechnology companies. GNS Healthcare is the information guru between drug makers and drug buyers matching drugs to patients to deliver on the promise of "smart" medicine.

For more information, contact Thomas A. Neyarapally, 617-494-0492.


'/>"/>
SOURCE GNS Healthcare, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization (IVF)
2. NEXUS Biosystems Acquires Tecan Groups REMP Sample Management Business
3. NEXUS Biosystems Completes Acquisition of REMP Sample Management Business From Tecan Group
4. Biosystems International Merges With Microbiochips
5. Incept BioSystems Completes First Human Clinical Trial of the SMART Start™ Embryo Culture System and Submits 510(k) Application to the FDA
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
11. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) ... Chronic Obstructive Pulmonary Disease (COPD) is a ... airways and lungs. Persistent breathing difficulties and repeated ... of the leading causes of morbidity and the ... is linked to cumulative exposure to risk factors, ...
(Date:2/4/2016)... ALBANY, N.Y. , Feb. 4, 2016  AMRI (NASDAQ: ... Vice President of Pfizer Inc. and President of Pfizer Global ... effective as of February 4, 2016. In addition, the Company ... member of the audit committee since 2010, has retired from ... time and attention to his other business ventures.  ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV show, ... much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream on ... week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors - ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... your life? The answer may be at the tips of your toes. Foot massage, ... benefits as well as pure comfort and relaxation. The American Board of Multiple ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth quarter of ... at the La Valencia Hotel in San Diego, California to discuss changes in ... year’s most outstanding franchise, walking away with the coveted David Wright Award of ...
(Date:2/5/2016)... ... 2016 , ... Pivot Point Consulting, a leading national Healthcare ... Services for HIT Implementation Support & Staffing report with an outstanding score of ... healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. , ...
(Date:2/5/2016)... ... , ... Colorize is a web theme package created exclusively for ... Colorize's dynamic moving camera. Colorize is perfect for personal and web related videos and ... 1 to 5 focus points per scene, stage floor scene presets that are great ...
Breaking Medicine News(10 mins):